Biomedical applications drug release

Chemical structure of monomers and intermediates was confirmed by FT-IR and FT-NMR. Molecular weight distribution of polymers was assessed by GPC and intrinsic viscosity. The thermal property was examined by differential scanning calorimetry. The hydrolytic stability of the polymers was studied under in vitro conditions. With controlled drug delivery as one of the biomedical applications in mind, release studies of 5-fluorouracil and methotrexate from two of these polymers were also conducted. 

The use of polymers for biomedical applications has been widely accepted since the 1960 s (7), and specifically for controlled release applications since the 1970 s (2). The primary goal of this research was to create a controlled release matrix from polymers with pre-existing Food and Drug Administration (FDA) histories, which would be capable of releasing insoluble active agents, and upon exhaustion of the device, leave a stable, inert, removable skeleton. The application of such a matrix would be as an intracervical device which would prevent both conception and ascending infection. 

Drug Release from PHEMA-l-PIB Networks. Amphiphilic networks due to their distinct microphase separated hydrophobic-hydrophilic domain structure posses potential for biomedical applications. Similar microphase separated materials such as poly(HEMA- -styrene-6-HEMA), poly(HEMA-6-dimethylsiloxane- -HEMA), and poly(HEMA-6-butadiene- -HEMA) triblock copolymers have demonstrated better antithromogenic properties to any of the respective homopolymers (5-S). Amphiphilic networks are speculated to demonstrate better biocompatibility than either PIB or PHEMA because of their hydrophilic-hydrophobic microdomain structure. These unique structures may also be useful as swellable drug delivery matrices for both hydrophilic and lipophilic drugs due to their amphiphilic nature. Preliminary experiments with theophylline as a model for a water soluble drug were conducted to determine the release characteristics of the system. Experiments with lipophilic drugs are the subject of ongoing research. 

The past two decades have produced a revival of interest in the synthesis of polyanhydrides for biomedical applications. These materials offer a unique combination of properties that includes hydrolytically labile backbone, hydrophobic bulk, and very flexible chemistry that can be combined with other functional groups to develop polymers with novel physical and chemical properties. This combination of properties leads to erosion kinetics that is primarily surface eroding and offers the potential to stabilize macromolecular drugs and extend release profiles from days to years. The microstructural characteristics and inhomogeneities of multi-component systems offer an additional dimension of drug release kinetics that can be exploited to tailor drug release profiles. 

This contribution will provide a review of polylectrolytes as biomaterials, with emphasis on recent developments. The first section will provide an overview of methods of synthesizing polyelectrolytes in the structures that are most commonly employed for biomedical applications linear polymers, crosslinked networks, and polymer grafts. In the remaining sections, the salient features of polyelectrolyte thermodynamics and the applications of polyelectrolytes for dental adhesives and restoratives, controlled release devices, polymeric drugs, prodrugs, or adjuvants, and biocompatibilizers will be discussed. These topics have been reviewed in the past, therefore previous reviews are cited and only the recent developments are considered here. 

Banga A, Chien Y. Iontophoretic delivery of drugs fundamentals, developments and biomedical applications. J Control Release 1988 7 1-24. 

Early development of polymers in injectable drug delivery primarily involved PLA and poly(lactic-co-glycolic) acid (PLGA) due to the prior use of these polymers in biomedical applications as sutures. Besides the safe and biocompatible nature of these polymers, their ease of availability made them ideal first candidates for screening parenteral CR formulations. Some of the early biodegradable polymer-based products for injectable sustained release used these polymers. However because... 

The very large absorption cross-sections of Au nanoparticles give rise to photothermal effects, that is, an increase in local temperature upon plasmon resonance excitation. The concept of Au nanoparticles as photothermal transducers has inspired numerous efforts to develop biomedical applications such as localized hyperthermal therapy,63-65 photothermal contrast agents,66 and optothermally controlled drug release,67-69 and also novel platforms for information storage.70... 

In their further studies on chitosan for biomedical applications, Lee et al. [133] reported a procedure for preparing semi-IPN polymer network hydrogels composed of (3-chitosan and PEG diacrylate macromer, by following a similar procedure to that discussed above. The crystallinity as well as thermal and mechanical properties of gels were reported [133]. Reports on the drug release behavior of the gels are not available. 

In addition to microelectronic and optical applications, polymers deposited using thermal and plasma assisted CVD are increasingly being used in several biomedical applications as well. For instance, drug particles microencapsulated with parylenes provide effective control release activity. Plasma polymerized tetrafiuoroethylene, parylenes and ethylene/nitrogen mixtures can be used as blood compatible materials. An excellent review of plasma polymers used in biomedical applications can be found in reference 131. 

Polyanhydrides are a class of bioerodible polymers that have shown excellent characteristics as drug delivery carriers. The properties of these biomaterials can be tailored to obtain desirable controlled release characteristics. Extensive research in this promising area of biomaterials is the focus of this entry. In the first part of the entry, the chemical structures and synthesis methods of various polyanhydrides are discussed. This is followed by a discussion of the physical, chemical, and thermal properties of polyanhydrides and their effect on the degradation mechanism of these materials. Finally, a description of drug release applications from polyanhydride systems is presented, highlighting their potential in biomedical applications. 

---